dihexa approval status fda Dato-DXd Earns Accelerated in Pretreated EGFR-Mutated mNSCLC Dihexa Peptide: Unlocking Brain Repair,

11: Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Penovic T, Drazenovic D, Becejac T, Tepes M, Madzar Z, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

Until rigorous studies show that BPC-157 does not awaken any sleeping dragons (like micrometastases), its best viewed with deep skepticism

The article will be updated following the July 2026 FDA Pharmacy Compounding Advisory Committee vote

Cagrilintide shows the same clumping sensitivity seen with many amylin-class peptides